검색
Barinthus Biotherapeutics PLC
BRNS관심 목록에 추가
0.558USD
+0.007+1.29%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
22.79M시가총액
손실P/E TTM
자세한 내용은 Barinthus Biotherapeutics PLC 회사
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company focused on developing immunotherapeutic candidates for treating autoimmune and inflammatory diseases. The Company’s pipeline, built around platform technologies; viral vector-based, consists of ChAdOx and MVA, and synthetic, consisting of SNAP-Tolerance Immunotherapy (SNAP-TI). These platforms help to develop antigen-specific immunotherapeutic candidates designed to optimize the disease fighting capabilities of T cells. It is focused on developing two product candidates that harness its viral vector and synthetic platform technologies. These include VTP-300, a Phase II immunotherapeutic candidate designed as a potential component of a functional cure for chronic hepatitis B virus infection utilizing ChAdOx/MVA, and VTP-1000, its autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease. The Company's pipeline also includes VTP-850, VTP-500 and VTP-400.
Barinthus Biotherapeutics PLC 정보
종목 코드 BRNS
회사 이름Barinthus Biotherapeutics PLC
상장일Apr 30, 2021
CEOEnright (William J)
직원 수105
유형Depository Receipt
회계 연도 종료Apr 30
주소Unit 6-10, Zeus Building, Rutherford Avenue
도시DIDCOT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United Kingdom
우편 번호OX11 0DF
전화441865818808
웹사이트https://www.barinthusbio.com/
종목 코드 BRNS
상장일Apr 30, 2021
CEOEnright (William J)
Barinthus Biotherapeutics PLC의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Geoffrey Lynn
Dr. Geoffrey Lynn
Chief Scientific Officer
Chief Scientific Officer
640.64K
--
Mr. Robin Wright
Mr. Robin Wright
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
48.26K
--
Dr. Pierre A. Morgon, Pharm.D.
Dr. Pierre A. Morgon, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
10.51K
--
Dr. Anne M. Phillips, M.D.
Dr. Anne M. Phillips, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
3.00K
--
Mr. William J. (Bill) Enright
Mr. William J. (Bill) Enright
Chief Executive Officer, Principal Financial Officer, Director
Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Alex Hammacher
Dr. Alex Hammacher
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen T. Dawes
Ms. Karen T. Dawes
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Joseph C. Scheeren
Dr. Joseph C. Scheeren
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Leon Hooftman, M.D.
Dr. Leon Hooftman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Geoffrey Lynn
Dr. Geoffrey Lynn
Chief Scientific Officer
Chief Scientific Officer
640.64K
--
Mr. Robin Wright
Mr. Robin Wright
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
48.26K
--
Dr. Pierre A. Morgon, Pharm.D.
Dr. Pierre A. Morgon, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
10.51K
--
Dr. Anne M. Phillips, M.D.
Dr. Anne M. Phillips, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
3.00K
--
Mr. William J. (Bill) Enright
Mr. William J. (Bill) Enright
Chief Executive Officer, Principal Financial Officer, Director
Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Alex Hammacher
Dr. Alex Hammacher
Non-Executive Director
Non-Executive Director
--
--
자주 묻는 질문
Barinthus Biotherapeutics PLC의 상위 5대 주주는 누구인가요?
Barinthus Biotherapeutics PLC의 상위 5대 주주는 다음과 같습니다: Dr. Geoffrey Lynn
Barinthus Biotherapeutics PLC(BRNS)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Barinthus Biotherapeutics PLC의 주식을 보유한 기관은 총 32곳이며, 이들이 보유한 주식의 총 가치는 약 16.70M로 전체 발행 주식의 40.87%를 차지합니다. 이는 2025Q4 대비 -1943125.00 증가한 수치입니다.